Insiders · Profile

RICKS THOMAS G

Director at Ovintiv · Director at Faeth Therapeutics. Filing since 21 Feb 2020. CIK 0001013023

Company
Date
Role
Action
Shares
Amount
Of holding
7 Jun 2022
Director
Sold, plan not stated
19,231
$1.14M
14.2%
23 May 2022
Director
Sold, plan not stated
10,000
$500.00K
6.9%
18 Apr 2022
Director
Sold, plan not stated
10,000
$537.30K
6.4%
31 Mar 2022
Director
Bought
19
no price
0.0%
10 Dec 2021
Director
Bought
20,000
$117.20K
6.2%
9 Dec 2021
Director
Bought
20,000
$132.40K
6.6%
18 Mar 2020
Director
Bought
50,000
$107.50K
47.4%
9 Mar 2020
Director
Bought
65,000
$203.45K
160%
27 Feb 2020
Director
Bought
25,000
$267.65K
161%
21 Feb 2020
Director
Bought
15,500
$245.99K
opened
10 decisions on file.